| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |